EKSO Q3 2019 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+30.2% YoY

Gross Profit

$2M52.7% margin

Operating Income

-$4M-114.2% margin

Net Income

$206,0006.2% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$497,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$14M

Stockholders' Equity

$6M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+30.2%
Gross Profit	$2M	$1M	+61.6%
Operating Income	-$4M	-$6M	+37.8%
Net Income	$206,000	-$7M	+103.0%

Revenue Segments

Product

$3M80%

Service

$567,00017%

Product and Service, Other

$72,0002%

Collaborative Arrangements

$18,0001%

Geographic Segments

UNITED STATES

$2M58%

Non-US

$1M42%